A Phase 3b, Multi-Center, Randomized, Open-Label, Pragma

Project: Research project

Project Details

Description

A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C previously treated with an NS5A Inhibitor + Sofosbuvir Therapy? (Protocol number B16-439; or DAA-SALVAGE
StatusFinished
Effective start/end date3/20/1712/31/18

Funding

  • University of Florida

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.